Great West Life Assurance CO United Therapeutics Corp Transaction History

Great West Life Assurance CO

  • $57.4 Billion
  • Q3 2024

A detailed history of Great West Life Assurance CO transactions in United Therapeutics Corp stock. As of the latest transaction made, Great West Life Assurance CO holds 66,279 shares of UTHR stock, worth $23.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
66,279
Previous 65,335 1.44%
Holding current value
$23.8 Million
Previous $20.8 Million 14.04%
% of portfolio
0.04%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$311.04 - $363.55 $293,621 - $343,191
944 Added 1.44%
66,279 $23.8 Million
Q2 2024

Aug 12, 2024
BUY
$228.26 - $319.04 $2.21 Million - $3.09 Million
9,671 Added 17.37%
65,335 $20.8 Million
Q1 2024

May 13, 2024
SELL
$210.76 - $249.51 $678,436 - $803,172
-3,219 Reduced 5.47%
55,664 $12.8 Million
Q4 2023

Feb 13, 2024
SELL
$214.88 - $256.94 $2.58 Million - $3.09 Million
-12,020 Reduced 16.95%
58,883 $12.9 Million
Q3 2023

Nov 14, 2023
BUY
$211.82 - $248.24 $1.22 Million - $1.43 Million
5,760 Added 8.84%
70,903 $16 Million
Q2 2023

Aug 10, 2023
BUY
$205.19 - $232.99 $4.49 Million - $5.1 Million
21,878 Added 50.57%
65,143 $14.4 Million
Q1 2023

May 12, 2023
BUY
$212.99 - $276.17 $865,591 - $1.12 Million
4,064 Added 10.37%
43,265 $9.69 Million
Q4 2022

Feb 10, 2023
BUY
$205.95 - $280.43 $1.11 Million - $1.51 Million
5,386 Added 15.93%
39,201 $10.9 Million
Q3 2022

Nov 01, 2022
BUY
$203.3 - $244.17 $6.87 Million - $8.26 Million
33,815 New
33,815 $7.07 Million
Q2 2022

Aug 09, 2022
BUY
$174.81 - $241.14 $718,818 - $991,567
4,112 Added 14.52%
32,438 $7.65 Million
Q1 2022

May 12, 2022
BUY
$166.16 - $213.96 $385,491 - $496,387
2,320 Added 8.92%
28,326 $5.24 Million
Q4 2021

Feb 14, 2022
BUY
$184.32 - $216.08 $286,617 - $336,004
1,555 Added 6.36%
26,006 $5.61 Million
Q3 2021

Nov 15, 2021
BUY
$179.86 - $214.88 $1.11 Million - $1.33 Million
6,185 Added 33.86%
24,451 $4.55 Million
Q2 2021

Aug 11, 2021
SELL
$170.47 - $211.93 $603,122 - $749,808
-3,538 Reduced 16.23%
18,266 $3.28 Million
Q1 2021

May 17, 2021
SELL
$153.94 - $174.85 $262,467 - $298,119
-1,705 Reduced 7.25%
21,804 $3.64 Million
Q4 2020

Feb 16, 2021
BUY
$101.87 - $151.79 $178,170 - $265,480
1,749 Added 8.04%
23,509 $3.57 Million
Q3 2020

Nov 13, 2020
SELL
$99.9 - $121.13 $20,679 - $25,073
-207 Reduced 0.94%
21,760 $2.2 Million
Q2 2020

Aug 17, 2020
SELL
$92.74 - $125.82 $88,566 - $120,158
-955 Reduced 4.17%
21,967 $2.65 Million
Q1 2020

May 14, 2020
BUY
$79.39 - $115.35 $114,242 - $165,988
1,439 Added 6.7%
22,922 $2.18 Million
Q4 2019

Feb 11, 2020
BUY
$78.31 - $95.34 $1.68 Million - $2.05 Million
21,483 New
21,483 $1.89 Million
Q3 2019

Oct 25, 2019
SELL
$74.85 - $85.99 $1.96 Million - $2.26 Million
-26,229 Closed
0 $0
Q2 2019

Jul 31, 2019
SELL
$76.06 - $120.81 $5.7 Million - $9.05 Million
-74,904 Reduced 74.06%
26,229 $0
Q1 2019

May 08, 2019
BUY
$107.15 - $126.84 $402,562 - $476,537
3,757 Added 3.86%
101,133 $11.8 Million
Q4 2018

Feb 12, 2019
SELL
$101.4 - $128.73 $1.52 Million - $1.93 Million
-14,989 Reduced 13.34%
97,376 $10 Million
Q3 2018

Nov 13, 2018
SELL
$113.81 - $129.46 $752,284 - $855,730
-6,610 Reduced 5.56%
112,365 $14.4 Million
Q2 2018

Aug 10, 2018
BUY
$101.14 - $118.31 $1.11 Million - $1.29 Million
10,941 Added 10.13%
118,975 $13.5 Million
Q1 2018

May 10, 2018
BUY
$107.21 - $151.94 $474,082 - $671,878
4,422 Added 4.27%
108,034 $12.1 Million
Q4 2017

Feb 09, 2018
SELL
$118.58 - $151.28 $3.08 Million - $3.93 Million
-25,956 Reduced 20.03%
103,612 $15.3 Million
Q3 2017

Nov 09, 2017
BUY
$114.6 - $136.81 $14.8 Million - $17.7 Million
129,568
129,568 $15.4 Million

Others Institutions Holding UTHR

# of Institutions
671
Shares Held
42.3M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email